Searchable abstracts of presentations at key conferences in endocrinology

ea0029p1654 | Thyroid (non-cancer) | ICEECE2012

Review of a thyrotoxicosis shared-care scheme: treatment choice and outcomes

Howlett T. , Kieffer V. , Robinson C. , Peat I. , Kong M. , Gleeson H. , Levy M.

Since 1994, after initial outpatient review (OPD) for thyrotoxicosis, we have minimised OPD attendance and provided shared-care advice to primary care physicians on thyroid function tests (TFT) and anti-thyroid drug (ATD) and levothyroxine (T4) dose titration using our electronic patient record (EPR). Using EPR data we analysed treatment (Rx) choice, effectiveness and outcomes, classifying patients as autoimmune (+ve TPO or other GravesÂ’ features), nodular, mix...

ea0015p392 | Thyroid | SFEBES2008

Audit of outcomes of radioiodine treatment for benign thyroid disease

Bejinariu Emanuela , Crasto Winston , Elrishi Mohamed A , Levy Miles J , Peat I , Howlett Trevor A

Objective: To assess the effect of antithyroid drug pretreatment on radioiodine (I-131) treatment outcomes for benign thyroid disease.Method: Retrospective analysis of all patient records on the clinical database that underwent I-131 treatment for benign thyroid disease between 1989 and 2007.Results: About 544 patients were identified, 98 males (18%) and 446 females (82%). The mean age was 54 years (11-88). 464 patients (85.3%) we...